Fraudulent Botox products may exist. Always check the translucent silver Allergan seal is intact on the Botox carton labeling. or the vial label contains a holographic film with the name Allergan with rainbow-colored horizontal lines on it, and there is a U.S. license number 1145 on the vial label and carton labeling. When used to treat bladder dysfunction, patients should not have a post-void residual (PVR) urine volume of more than 200mL if they are not self-catheterizing, nor a urinary tract infection (UTI) at the time of the appointment.
Limiting the dose injected into the sternocleidomastoid muscle may reduce the occurrence of dysphagia. Injections into the levator scapulae may be associated with an increased risk of upper respiratory infection and dysphagia.
Call your healthcare provider or get emergency medical help if you have any of these problems after treatment with Botox:
Getting "too much" Botox often means exceeding the amount needed for this subtle result, leading to undesirable cosmetic outcomes or potentially increasing side effect risks. It is important to be treated by a qualified, experienced medical professional (like a board-certified dermatologist, plastic surgeon, or properly trained nurse practitioner/physician assistant under supervision) who understands anatomy and appropriate dosing.
In general, the initial effect of the injections is seen within three days and reaches a peak at one to two weeks post-treatment. Each treatment lasts approximately three months, following which the procedure can be repeated. At repeat treatment sessions, the dose may be increased up to two-fold if the response from the initial treatment is considered insufficient, usually defined as an effect that does not last longer than two months.
Botox for medical conditions should only be injected by a trained healthcare provider who can ensure:
The goal of cosmetic Botox is typically to soften wrinkles and achieve a refreshed, conterraneo look, not to eliminate all movement. Botox is also available to treat certain medical conditions.
Patients experiencing adequate paralysis of the target muscle that require subsequent injections should receive a dose comparable to the initial dose.
Reduced blinking from BOTOX injection of the orbicularis muscle can lead to corneal exposure, persistent epithelial defect, and corneal ulceration, especially in patients with VII nerve disorders.
Detrusor Overactivity associated with a Neurologic Condition An intravesical instillation of diluted local anesthetic with or without sedation, or general anesthesia may be used prior to injection, per local site practice.
Overcorrections lasting over six months have been rare. About one half of patients will require subsequent doses because of inadequate paralytic response of the muscle to the initial dose, or because of mechanical factors such as large deviations or restrictions, or because of the lack of binocular motor fusion to stabilize the alignment.
Several other types of spastic movement disorders and some other long-term conditions not effectively treated by other types of medical treatment also have reported success with botulinum toxins. The medical botox uses for botulinum toxins are likely to expand in the future.
Reconstituted BOTOX should be clear, colorless, and free of particulate matter. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration and whenever the solution and the container permit.
BOTOX is indicated for the treatment of severe primary axillary hyperhidrosis that is inadequately managed with topical agents.